Security key
H0036K147
ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT)
CUSIP: H0036K147
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Shares, par value CHF 0.08 per share
- Shares outstanding
- 128,459,465
- Total 13F shares
- 54,846,167
- Share change
- -1,623,520
- Total reported value
- $77,332,587
- Put/Call ratio
- 152%
- Price per share
- $1.41
- Number of holders
- 82
- Value change
- -$2,528,133
- Number of buys
- 38
- Number of sells
- 33
Report period
Q1 2025
Institutions
82
Top holders
10
ADCT full security history
Newer quarter: Q2 2025
Previous quarter: Q4 2024
ADC Therapeutics SA SEC filings
ADC Therapeutics SA company facts
Broader feeds
Reporting periods
Holder history for CUSIP H0036K147
Recent filing periods:
Top shareholders of ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Redmile Group, LLC |
13F
|
Company |
12%
|
15,666,731
|
$31,176,795 | — | 31 Dec 2024 | |
| Prosight Management, LP |
13F
|
Company |
7.4%
|
9,515,000
|
$18,934,850 | — | 31 Dec 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
4.6%
|
5,968,451
|
$11,877,217 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
5%
from 13D/G
|
5,011,857
|
$9,973,595 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
3.1%
|
3,956,172
|
$7,872,781 | — | 31 Dec 2024 | |
| Woodline Partners LP |
13F
|
Company |
1.5%
|
1,933,751
|
$3,848,164 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.3%
|
1,673,177
|
$3,329,623 | — | 31 Dec 2024 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
1.3%
|
1,612,556
|
$3,208,986 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1%
|
1,291,244
|
$2,569,576 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.92%
|
1,188,194
|
$2,364,506 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.75%
|
963,109
|
$1,916,586 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.69%
|
884,518
|
$1,760,191 | — | 31 Dec 2024 | |
| Vantage Consulting Group Inc |
13F
|
Company |
0.66%
|
850,737
|
$1,692,967 | — | 31 Dec 2024 | |
| Blue Owl Capital Holdings LP |
13F
|
Company |
0.57%
|
733,568
|
$1,459,800 | — | 31 Dec 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.56%
|
716,668
|
$1,426,169 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.5%
|
644,618
|
$1,282,789 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.37%
|
476,193
|
$947,623 | — | 31 Dec 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.32%
|
411,124
|
$818,137 | — | 31 Dec 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.2%
|
253,342
|
$504,150 | — | 31 Dec 2024 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.17%
|
224,081
|
$445,921 | — | 31 Dec 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.15%
|
194,258
|
$386,573 | — | 31 Dec 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.14%
|
183,231
|
$364,630 | — | 31 Dec 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.13%
|
171,993
|
$342,265 | — | 31 Dec 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.12%
|
152,047
|
$302,574 | — | 31 Dec 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.11%
|
141,495
|
$281,575 | — | 31 Dec 2024 | |
| FMR LLC |
13F
|
Company |
0.1%
|
127,019
|
$252,768 | — | 31 Dec 2024 | |
| Florida Trust Wealth Management Co |
13F
|
Company |
0.09%
|
113,000
|
$224,870 | — | 31 Dec 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.09%
|
110,037
|
$218,963 | — | 31 Dec 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.08%
|
107,231
|
$213,390 | — | 31 Dec 2024 | |
| Wilmington Savings Fund Society, FSB |
13F
|
Company |
0.08%
|
100,000
|
$199,000 | — | 31 Dec 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.05%
|
65,267
|
$129,881 | — | 31 Dec 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.05%
|
64,139
|
$127,636 | — | 31 Dec 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.04%
|
56,062
|
$111,563 | — | 31 Dec 2024 | |
| Magnetar Financial LLC |
13F
|
Company |
0.04%
|
55,762
|
$110,966 | — | 31 Dec 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.04%
|
51,198
|
$101,884 | — | 31 Dec 2024 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.04%
|
46,520
|
$92,575 | — | 31 Dec 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.03%
|
41,832
|
$83,246 | — | 31 Dec 2024 | |
| Corebridge Financial, Inc. |
13F
|
Company |
0.03%
|
40,430
|
$80,456 | — | 31 Dec 2024 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.03%
|
39,611
|
$79,000 | — | 31 Dec 2024 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.03%
|
39,362
|
$78,330 | — | 31 Dec 2024 | |
| INTECH INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.03%
|
38,435
|
$76,486 | — | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.03%
|
37,021
|
$73,671 | — | 31 Dec 2024 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.03%
|
36,140
|
$72,000 | — | 31 Dec 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.03%
|
34,369
|
$68,395 | — | 31 Dec 2024 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.02%
|
31,117
|
$61,923 | — | 31 Dec 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.02%
|
28,831
|
$58,000 | — | 31 Dec 2024 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.02%
|
28,588
|
$56,890 | — | 31 Dec 2024 | |
| DLK Investment Management, LLC |
13F
|
Company |
0.02%
|
25,805
|
$51,352 | — | 31 Dec 2024 | |
| LPL Financial LLC |
13F
|
Company |
0.02%
|
25,000
|
$49,750 | — | 31 Dec 2024 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.02%
|
23,786
|
$47,334 | — | 31 Dec 2024 |
Institutional Holders of ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT) as of Q1 2025
As of 31 Mar 2025,
ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT) was held by
82 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
54,846,167 shares.
The largest 10 holders included
Redmile Group, LLC, Prosight Management, LP, ORBIMED ADVISORS LLC, BlackRock, Inc., MORGAN STANLEY, PLATINUM INVESTMENT MANAGEMENT LTD, BANK OF AMERICA CORP /DE/, GOLDMAN SACHS GROUP INC, STATE STREET CORP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
81
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
82
Q1 2025 holders
82
Holder diff
0
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.